University of Illinois Chicago clinical trial pipeline
Data updated daily from ClinicalTrials.gov, last refresh 2026-11-05
What changed in the last 30 days
18 trials changed in the last 30 days: 0 stopped, 15 with notable changes, 3 with minor changes only.
- Minor: Locally Delivered Allogeneic Mesenchymal Stromal Cells Primary and study completion pushed from Sep 28, 2026 to Dec 28, 2026
- Notable: Topical Mesenchymal Stromal Cell Secretome for Ocular Surface Disease Primary and study completion dates pushed to Dec 15, 2026
- Notable: Facilitating Advance Care Planning Discussions · Advanced Cancer Results posted: Oct 28, 2026
- Notable: MADRE · (Mammograms Available Due to Research and Education) Primary completion pushed from Sep 30, 2026 to Aug 31, 2027
- Notable: MindCRC · Targeting Chronic Stress for Reducing Risk Factors for Colorectal Cancer Results posted: Oct 27, 2026
- Notable: HEME-25 · Elranatamab Utilized as Consolidation in Newly Diagnosed Plasmablastic Lymphoma With or Without HIV Recruitment opened
- Minor: TRE-Preg · Time-restricted Eating Among Pregnant Females With Severe Obesity Enrollment closed, study ongoing
- Notable: Intensity Modulated Total Marrow Irradiation (IM-TMI) in Addition to Fludarabine/Busulfan Conditioning for Allogeneic Transplantation in High Risk AML and Myelodysplastic Syndromes Primary and study completion pushed from Apr 2026 to Nov 2026
- Notable: MOMS-AD · Maternal Outcomes: Mood, Alcohol Use, and Depressive Symptoms Recruitment opened
- Notable: EEG Biomarkers for OUD: Diagnostic, Prognostic, and Predictive Applications Primary completion date changed from estimate of Sep 15, 2025 to Sep 15, 2026
- Notable: CARES · CKD Awareness, Referrals, Education, and Support Intervention for Early-Stage CKD Primary completion pushed from Apr 30, 2026 to Dec 30, 2026
- Notable: OTW · Track for Wellness (OTW) Stepped Wedge Cluster Randomized Trial Primary completion pushed from Sep 1, 2029 to Sep 1, 2030
- Notable: MSC Secretome · Topical Mesenchymal Stromal Cell Secretome for Ocular Surface Disease Results posted: Oct 7, 2026
- Minor: P2P · PATH 2 Purpose: Primary Care and Community-Based Prevention of Mental Disorders in Adolescents Trial completed
- Notable: MGMC · Melanated Group Midwifery Care Primary completion pushed from May 15, 2026 to Jan 15, 2027
- Notable: Monitoring Occupational Dental Stress Using Apple Watch Primary completion pushed from Jun 1, 2027 to Jun 1, 2028
- Notable: Apple Watch Evaluation of Endodontics Occupational Stress Primary completion pushed from May 15, 2027 to May 15, 2028
- Notable: MS · Remotely Delivered Pilates on Physical , and Psychological Outcomes · Multiple Sclerosis Recruitment opened
- Stopped: terminated, suspended or withdrawn
- Notable: the plan changed
- Minor: routine updates
New trial filings, last 30 days
| First posted | Trial | Phase | Status |
|---|---|---|---|
| 2026-10-09 | NCT07869355 BRE-13: Mediterranean Diet | Not Yet Recruiting |
Active trials by phase
| Early Phase 1 | 5 | |
| Phase 1 | 5 | |
| Phase 1/2 | 3 | |
| Phase 2 | 22 | |
| Phase 2/3 | 1 | |
| Phase 3 | 2 | |
| Phase 4 | 5 |
Not charted: 119 active trials with no phase listed on ClinicalTrials.gov (typically behavioural, device, procedure and observational studies).
Disease areas by active trials, top 10 of 40
Breast Cancer (13) · Depression (13) · Diabetes (10) · Obesity (10) · Stroke (10) · Multiple Sclerosis (9) · Anxiety (6) · Heart Disease (5) · Sickle Cell Disease (5) · Lung Cancer (4)
Get alerts when University of Illinois Chicago's trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.